A Single Center, Open-label, Single Cohort, Fixed Sequence Trial, Investigating the Influence of HRS9531 Injection on Pharmacokinetics of Metformin in Healthy Subjects
Latest Information Update: 28 Oct 2024
At a glance
- Drugs HRS 9531 (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Fujian Shengdi Pharmaceutical
- 28 Oct 2024 New trial record